Gracell Biotechnologies Inc. (NASDAQ:GRCL) Q3 2023 Earnings Conference Call November 13, 2023 8:00 AM ET
Company Participants
William Cao - Chairman and CEO
Wendy Li - Chief Medical Officer
Kevin Xie - CFO
Conference Call Participants
Yigal Nochomovitz - Citi
Benjamin Burnett - Stifel
Dev Prasad - Jefferies
Eric Schmidt - Cantor
Emily Bodnar - H.C. Wainwright
Yanan Zhu - Wells Fargo Securities
Joseph Catanzaro - Piper Sandler
Justin Zelin - BTIG
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Gracell Biotechnologies Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After opening remarks, we will open the call for questions. Instructions for queuing up will be given at that time.
I will now turn the conference call over to Dr. Kevin Xie, Chief Financial Officer. Please go ahead.
Kevin Xie
Good morning, and welcome to Gracell third quarter 2023 corporate update conference call and webcast. With me today are Gracell Founder and Chief Executive Officer, Dr. William Cao; and our Chief Medical Officer, Dr. Wendy Li. We're excited to discuss the advancement of the trials underway with our CAR-T candidate on today's call.
We're looking forward to share with you our recent business developments and upcoming objectives as we have six weeks remaining in 2023 and are looking forward to 2024. As a reminder, we'll conduct a question-and-answer session following our formal remarks.
This morning, Gracell issued a press release announcing unaudited financial results for the third quarter ended September 30, 2023. We encourage everyone to read this press release, I would like to remind you that this call is being recorded for replay. Please note that for certain information discussed on the call today, including financial data, clinical data, future plans of our program, resource management will be making forward-looking statements.
Actual results could differ materially from those stated or implied by those forward-looking statements as a result of various important factors, and please refer to the Risk Factors section of our latest 20-F filings with SEC for a full disclosure of these risks and factors. This conference call contains time-sensitive information that is accurate only as of the date of the live forecast, November 13, 2023.
Gracell undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by applicable securities law.